Clinical observation of low dose sufentanil in preventing shivering and pulling pain during cesarean section anesthesia
10.3969/j.issn.1005-1678.2017.08.059
- VernacularTitle:小剂量舒芬太尼在剖宫产术麻醉中预防寒战和牵拉痛的临床观察
- Author:
Jianshu CHEN
;
Yulian QU
- Keywords:
small dose sufentanil;
cesarean section anesthesia;
prevention of shivering;
traction pain
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(8):147-148
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate and analyze the clinical observation of low dose sufentanil in the prevention of shivering and traction during cesarean section. Methods 100 cases of cesarean section in our hospital from January 2015 to December 2016 were selected and randomly divided into two groups, the control group and the experimental group, with 50 patients in each group. The control group received bupivacaine anesthesia, and the experimental group received sufentanil anesthesia on the basis of sufentanil. The clinical indexes of the experimental group and the control group were compared and analyzed. Results After the corresponding anesthesia, there was no moderate or severe traction pain in the experimental group and the control group, and 29 cases of mild traction pain in the control group, with a rate of 58%. There were 7 patients with mild traction pain in the experimental group, with a rate of 14%. The probability of mild traction pain in the experimental group was significantly lower than that in the control group, with statistical difference (P<0.05). The incidence of shivering in the experimental group was 16%, significantly lower than that in the control group, with a rate of 52%, which was statistically significant (P<0.05). The adverse reaction rate of the experimental group was 12%, significantly lower than that of the control group, the probability of occurrence was 42%, which was statistically significant (P<0.05). Conclusion The application of small dose of sufentanil in anesthesia in cesarean section can reduce the occurrence probability of visceral pain in a large extent, prevention of shivering, high safety, low incidence rate of adverse reaction, with further clinical promotion and application significance.
